Stephen B Howell

5PUBLICATIONS
16CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 12, 2024
Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia.

Himangshu Sonowal, William G Rice, Raphael Bejar

|Mar 08, 2023
Luxeptinib interferes with LYN-mediated activation of SYK and modulates BCR signaling in lymphoma.

Himangshu Sonowal, William G Rice, Stephen B Howell

|Feb 27, 2023
Exploiting the Receptor-Binding Domains of R-Spondin 1 to Target Leucine-Rich Repeat-Containin G-Coupled Protein Receptor 5-Expressing Stem Cells in Ovarian Cancer.

Clara Wong, Maria Carmen Mulero, Erika I Barth

|May 02, 2022
Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia.

William G Rice, Stephen B Howell, Hongying Zhang

|Jan 25, 2021
Therapeutic Targeting of Tumor Cells Rich in LGR Stem Cell Receptors.

Songman Yu, Maria Carmen Mulero, Wannan Chen

Pageof 1